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Abstract
Aminoglycosides (AG), including gentamicin (GM), are the most frequently used antibiotics in the world and are proposed
to cause irreversible cochlear damage and hearing loss (HL) in 1/4 of the patients receiving these life-saving drugs. Akin to
the results of AG ototoxicity studies, high-frequency, basal turn outer hair cells (OHCs) preferentially succumb to multiple HL
pathologies while inner hair cells (IHCs) are much more resilient. To determine if endogenous differences in IHC and OHC
mitochondrial metabolism dictate differential sensitivities to AG-induced HL, IHC- and OHC-specific changes in
mitochondrial reduced nicotinamide adenine dinucleotide (NADH) fluorescence during acute (1 h) GM treatment were
compared. GM-mediated decreases in NADH fluorescence and succinate dehydrogenase activity were observed shortly after
GM application. High-frequency basal turn OHCs were found to be metabolically biased to rapidly respond to alterations in
their microenvironment including GM and elevated glucose exposures. These metabolic biases may predispose high-
frequency OHCs to preferentially produce cell-damaging reactive oxygen species during traumatic challenge. Noise-induced
and age-related HL pathologies share key characteristics with AG ototoxicity, including preferential OHC loss and reactive
oxygen species production. Data from this report highlight the need to address the role of mitochondrial metabolism in
regulating AG ototoxicity and the need to illuminate how fundamental differences in IHC and OHC metabolism may dictate
differences in HC fate during multiple HL pathologies.
Citation: Jensen-Smith HC, Hallworth R, Nichols MG (2012) Gentamicin Rapidly Inhibits Mitochondrial Metabolism in High-Frequency Cochlear Outer Hair
Cells. PLoS ONE 7(6): e38471. doi:10.1371/journal.pone.0038471
Editor: Julio Francisco Turrens, University of South Alabama, United States of America
Received January 30, 2012; Accepted May 10, 2012; Published June 8, 2012
Copyright:  2012 Jensen-Smith et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: MGN was supported by R15-GM085776 (NIGM, NIH). This publication was also made possible by grants from the National Center for Research
Resources (5P20RR016469) and the National Institute for General Medical Science (NIGMS) (8P20GM103427), a component of the National Institutes of Health
(NIH). This research was conducted at the Integrated Biomedical Imaging Facility at Creighton University (CUIBIF), Omaha, NE. This facility, supported by the
Creighton University Medical School and Nebraska EPSCoR program, is part of a research space that was constructed with support from C06 Grant RR17417-01
from the National Center for Research Resources, NIH, USA. Animal care facilities for this project were supported by G20 RR024001 from the NCRR, NIH. This
investigation is solely the responsibility of the author and does not necessarily represent the official views of NIGMS, NCRR or NIH. The funders had no role in
study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: heathersmith@creighton.edu
Introduction
According to the World Health Organization, deafness and
hearing impairments affect more than 278 million individuals,
indicating hearing loss (HL) is the most frequent sensory deficit in
global populations. Aminoglycoside (AG) antibiotics are frequently
used to treat life-threatening gram-negative infections but their
clinical utility is limited due to nephrotoxicity and ototoxicity [1].
Unlike AG-induced nephrotoxicity, AG-induced ototoxicity is
irreversible and proposed to cause HL and/or deafness in 25% of
patients receiving these life-saving antibiotics [1,2]. Of the two
types of cochlear sensory hair cells, outer hair cells (OHCs) reliably
succumb to a barrage of AG-triggered pro-apoptotic signals, while
inner hair cells (IHCs) display a truncated pro-apoptotic signaling
response and greater survival, relative to OHCs [3–6]. Addition-
ally, when compared to apical turn, low-frequency processing
OHCs, basal turn, high-frequency processing OHCs are prefer-
entially damaged.
Although there are numerous causes of HL and deafness,
reactive oxygen species (ROS) are now well-known instigators of
multiple HL pathologies including: aminoglycoside (AG)-induced
ototoxicity (recent review: [7]), noise-induced (NIHL, [8,9]), and
age-related HL (ARHL, review: [10]). ROS are normal bypro-
ducts of ATP synthesis that can rise to lethal levels when
mitochondrial metabolism is perturbed. AGs have been shown to
enter inner hair cells and outer hair cells (I/OHCs) at the apical
pole and preferentially accumulate in mitochondria [11–13].
Gentamicin (GM), a representative AG antibiotic, has also been
shown to directly inhibit protein synthesis in human mitochondrial
ribosomes [14,15] and trigger mitochondrial permeability transi-
tion pore opening in cochlear HCs [16]. Likewise, mitochondrial
mutations are commonly associated with sensorineural HL [17–
20] and in some individuals a profound susceptibility to AG-
induced HL [14,21–24]. Others have also shown that cellular ATP
concentration can dictate commitment to apoptotic or necrotic cell
fates for multiple cell types [25–27]. For cochlear I/OHCs,
succinate dehydrogenase (SDH) activity, a mitochondrial enzyme,
is a key arbitrator of HC fate during acoustic trauma and exposure
to various ototoxic agents [28–31]. As such, intrinsic differences in
I/OHC mitochondrial metabolism may explain why high-
frequency OHCs are profoundly sensitive to mitochondrial-
mediated damage during various cochlear pathologies.
Mitochondrial metabolism couples oxidative phosphorylation
(the electron transport chain) to the generation of ATP. During
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oxidation is harnessed by transferring electrons from the reducing
agents NADH, FADH2 and succinate through a series of electron
carriers, including ubiquinone, in the inner mitochondrial
membrane. NADH, the primary electron donor/reducing agent,
is fluorescent (Fl) when reduced (NADH) and non-fluorescent
when oxidized (NAD
+). NADH Fl represents the net activities of
two opposing processes; Krebs cycle-mediated NADH reduction/
production (increases NADH Fl, NADH) and electron transport
chain-mediated NADH oxidation/utilization (decreases NADH Fl
by increasing NAD
+). If metabolic demands increase, the NADH/
NAD
+ ratio will, at least temporarily, decrease resulting in
a reduction in NADH Fl intensity. As such, mitochondrial
function can be evaluated by measuring real-time changes in
NADH Fl in intact cells [32,33]. Indeed, two-photon confocal
imaging of NADH Fl was recently used to observe real-time changes
in mitochondrial metabolism in living isolated cochlear prepara-
tions [34,35]. As indicated by a decrease in NADH Fl, these
studies revealed GM rapidly altered OHC, but not IHC,
mitochondrial metabolism. These results also suggested a GM-
induced decrease in ATP synthesis and presumably OHC
viability, occurred within minutes of GM exposure.
It is important to note that the Fl spectra of NADH and
nicotinamide adenine dinucleotide phosphate (NADPH) are
indistinguishable. NADPH is a reducing agent for lipid and amino
acid synthesis that is also capable of regenerating cellular
antioxidants (glutathione) and triggering free-radical production
in immune cells. As described in a previous study of NAD(P)H
metabolism in cochlear HCs, the contribution of NADH and
NADPH to the total NAD(P)H signal can be reasonably de-
termined by examining changes in NAD(P)H Fl during treatment
with the metabolic uncoupler FCCP and the metabolic poison
sodium cyanide [35]. By measuring NADH and flavoprotein Fl
during the aforementioned metabolic perturbations, Tiede at al.
confirmed NADH, not NADPH Fl, prevails in cochlear I/OHCs.
In light of the fact that NaCN and FCCP specifically alter
mitochondrial metabolism and that the sum of the relative
oxidation and reduction percentages for cochlear HCs always
totaled 100%, the observed changes in I/OHC NADH indicated
NADH Fl predominantly originated from mitochondrial sources.
Given these findings, the NADH Fl described in this report is
considered to be principally mitochondrial and comparatively free
of NADPH.
The current report uses acutely-cultured perinatal cochlear
explants to further probe the nature of the rapid, GM-induced
decrease in mitochondrial metabolism (the GM NADH effect) and
to determine if OHC-specific decreases in the NADH Fl are due to
increased NADH oxidation or decreased Krebs cycle-mediated
NADH reduction. In the freshly-dissected adult cochlea imaging
technique previously used [34,35], calcified bone prevented
transmitted light imaging to verify HC morphology and viability.
By using acutely-cultured perinatal cochlear explants, transmitted
light imaging of cellular morphology and HC viability can be
obtained throughout each experiment. During the acute (24 h)
culturing period, viable HCs will maintain organized stereocilia,
non-granular cytoplasm and will appropriately restrict cellular
swelling, while traumatized HCs will show morphological abnor-
malities, including splayed stereociliary bundles, plasma mem-
brane blebbing, swelling, and granular inclusions in the cytoplasm.
Finally, freshly-dissected cochlear preparations remain viable for
no more than 2 h after opening of the cochlea. Cultured
preparations, on the other hand, can be maintained for hours to
over one week [36] permitting reporter dye uptake for functional
analyses, as well as time to apply and evaluate the effects of
putative I/OHC-saving treatments.
Given that basal turn, high-frequency OHCs are reliably lost
during GM treatment, identification of the process(s) responsible
for the rapid GM-induced decrease in NADH Fl is critical for
developing new HL prevention strategies. By transitioning to the
acutely cultured technique, a host of new studies examining the
metabolic mechanisms mediating GM ototoxicity are possible.
Furthermore, by uncovering fundamental metabolic differences
between cochlear I/OHCs and the mechanisms mediating OHC-
specific decreases in the NADH Fl, this report provides critical
data for the development of additional HL prevention and
treatment strategies targeting multiple HL pathologies.
Results
Endogenous Differences in Cochlear IHC and OHC
Metabolism
Recall that baseline NADH Fl represents the opposing actions
of Krebs cycle-mediated NADH reduction/production and
electron transport-mediated NADH oxidation/utilization. Puta-
tive intrinsic differences in I/OHC mitochondrial metabolism
were assessed by examining baseline NADH Fl intensities in low-
and high-frequency I/OHCs. IHC and OHC endogenous NADH
Fl intensities were significantly different (Fig. 1A,B, black bar).
Baseline, endogenous NADH Fl in apical turn OHCs was greater
than that of apical turn IHCs (t(62)=4.31, p,0.001). The greatest
difference in endogenous NADH Fl intensity occurred between
basal turn IHCs (25.1960.93) and OHCs (39.7261.56,
t(64)=8.11, p,0.001).
Next, NADH was maximally reduced using 10 mM NaCN
(10 min) or maximally oxidized using 10 mM carbonylcyanide-p-
trifluoromethoxyphenylhydrazone (FCCP, 10 min) [35]. After
NaCN application, the absolute increase in NADH Fl was similar
for apical turn I/OHCs (Fig. 1A). In high-frequency regions of the
cochlea, OHCs displayed a larger increase in NADH Fl than
IHCs (Fig. 1B, t(14)=1.86, p,0.05). After FCCP application,
decreases in NADH Fl were greater in OHCs than in IHCs in
both low- and high-frequency regions of the cochlea (t(10)=2.7,
p,0.01, t(10)=4.49, p,0.01), respectively). Given that baseline
differences in NADH Fl exist between I/OHCs, a relative redox
state scale was calculated for apical and basal turn I/OHCs during
maximum NADH reduction and oxidation (Fig. 1C,D). The
relative redox scale indicates NaCN-induced maximum NADH
reduction is similar in low- and high-frequency I/OHCs. On the
other hand, relative differences in FCCP-induced maximum
NADH oxidation were significant between apical I/OHCs
(t(10)=2.22, p,0.05) and approached significance for basal turn
I/OHCs (p=0.054).
Differences in functional mitochondrial densities were de-
termined by examining relative differences in Mitotracker Red
CM-H2XRos Fl intensity in high- and low-frequency I/OHCs
(Fig. 1E). In both apical and basal regions of the cochlea, OHC
mitochondrial densities were greater than IHC mitochondrial
densities (t(7)=2.80, p,0.01, t(7)=2.77, p,0.01, respectively).
GM Rapidly Decreases NADH Fluorescence (GM NADH
Effect)
Akin to a previous experiment using freshly-dissected adult
cochleae [34], 300 mg/ml GM rapidly decreased NADH Fl in
cochlear OHCs housed in acutely-cultured, intact organ of
Corti explants from postnatal day 661 day mice (Fig. 2).
NADH Fl in apical turn, low-frequency I/OHCs was not
significantly altered by acute GM treatment (Fig. 2A). Although
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was observed at 60 min, this result was transient and failed to
intimate any difference between control and GM-treated OHCs.
In contrast to low-frequency, apical turn I/OHCs, basal turn,
high-frequency OHCs displayed a significant decrease in
NADH Fl intensity within 10 min of 300 mg/ml GM applica-
tion (t(7)=2.00, p,0.05, Fig. 2B). Basal turn OHCs maintained
a 10–12% decrease in NADH Fl intensity throughout the GM
exposure period while NADH Fl in basal turn IHCs remained
unaltered.
Figure 1. Endogenous differences in I/OHC NADH metabolism. A) Steady-state, endogenous NADH Fl in apical turn OHCs is greater than
apical turn IHCs (black line, t(62)=4.31, p,0.001, n=32). Absolute increases in NADH Fl during maximum NADH reduction (NaCN, n=8) were similar
for apical I/OHCs while maximum NADH oxidation (FCCP, n=6) caused a greater decrease in NADH Fl in apical OHCs than in apical IHCs (t(10)=4.49,
p,0.01). B) Steady-state, endogenous NADH Fl in basal turn OHCs is greater than basal turn IHCs (black line, t(64)=4.15, p,0.001, n=33). C)
Normalized increases in NADH Fl during maximum NADH reduction (NaCN, n=8) were similar for apical turn I/OHCs while decreases in NADH Fl
during maximum NADH oxidation (FCCP, n=6) were greater in OHCs than in IHCs (t(10)=2.22, p,0.05). D) Normalized increases in NADH Fl during
maximum NADH reduction and decreases in NADH Fl during maximum NADH oxidation were similar in basal turn I/OHCs. E) Relative differences in
Mitotracker Red Fl intensity indicated OHCs in both cochlear location contained more functional mitochondria than IHCs at each location (napex=7,
nbase=7). *=p,0.05, **=p,0.01, ***=p,0.001.
doi:10.1371/journal.pone.0038471.g001
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maintained similar NADH Fl intensities throughout the GM
exposure period, NADH Fl in GM-exposed basal turn OHCs was
significantly lower than in GM-exposed basal turn IHCs within
20 min (IHCs=1.02560.054, OHCs=0.89660.01, t(8)=3.014,
p,0.01). The significant suppression of NADH Fl in GM-exposed
basal turn OHCs, relative to GM-exposed basal turn IHCs,
remained after 1 h (IHCs=0.99760.063, OHCs=0.90060.051,
t(8)=1.897, p,0.05). Figures 2C and D represent basal turn I/
OHC NADH Fl before and after GM-exposure, respectively.
GM NADH Effect: NADH Oxidation Assay
If the GM NADH effect observed in basal turn OHCs was due
to an increase in energetic demand, NADH oxidation would
exceed NADH reduction resulting in a net decrease in NADH Fl.
Therefore, if the concentration of reduced NADH in I/OHCs was
significantly increased prior to GM application, the GM NADH
effect ought to be diminished. As described in Materials and
Methods, the baseline modified Tyrodes imaging buffer (T1), in
which the GM NADH effect was initially observed (Fig. 2),
contained 5 mM glucose. To increase NADH levels, a high-
glucose (10 mM) Krebs cycle-substrate modified (3 mM gluta-
mate, 2 mM pyruvate) imaging buffer (T2) was applied to the
cochlear preparations. T2 buffer significantly increased NADH Fl
in cochlear I/OHCs (Fig. 3A,B). Significant increases in NADH Fl
intensity in apical turn I/OHCs were observed at multiple time
points (Fig. 3A). A prolonged and large increase in NADH Fl
intensity occurred in basal turn OHCs (Fig. 3B) within 10 min of
T2 exposure (OHCsT1=1.02360.017, OHCsT2=1.13760.009,
t(7)=6.22, p,0.001). Basal turn OHCs maintained a ,15%
elevation in NADH Fl intensity throughout T2 exposure.
To determine if GM increases NADH oxidation (increased
energetic demand), 300 mg/ml GM was applied to cochlear
preparations pretreated (10–15 min) and subsequently maintained
in T2 buffer. Despite the previously described T2-mediated
increase in NADH (Fig. 3A, B), the GM NADH effect was still
observed (Fig. 3C, D). When bathed in T2 buffer, apical turn I/
OHCs displayed significant, yet transient decreases in NADH Fl
30 min after GM application (IHCcontrol=1.09960.013,
IHCGM=0.94160.027, OHCcontrol=1.06260.048,
OHCGM=0.93660.043, Fig. 3C). A significant and prolonged
decrease in NADH Fl was observed in basal turn OHCs while
Figure 2. Acute GM exposure decreased NADH Fl in basal turn OHCs bathed in T1 imaging buffer. A) I/OHCs in apical, low-frequency
regions of the cochlea do not show significant alterations in NADH Fl during acute GM exposure (nGM=5, n Cont=4). A transient difference was
observed in OHCs at 60 min (t(7)=1.96, p,0.05). B) Although basal turn, high-frequency IHCs were unaltered by GM, basal turn OHCs displayed
a significant decrease in NADH Fl within 10 min of GM exposure (t(7)=2.0, p,0.05, nGM=5,n Cont=4). C) Representative image of NADH Fl intensity in
basal turn I/OHCs before and after (D) GM exposure. The location of the IHC row and OHC rows are indicated by circling an individual HC from each
location. T1 imaging buffer contained 5 mM glucose. Scale bar=10 mm. *=p,0.05, **=p,0.01.
doi:10.1371/journal.pone.0038471.g002
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(Fig. 3D). The basal turn GM NADH effect was substantial and
prolonged, while the decrease in apical turn I/OHC NADH Fl
was transient. Apical turn, GM-exposed I/OHCs maintained
similar NADH Fl levels throughout the duration of the GM
exposure, while NADH Fl levels in GM-exposed basal turn OHCs
were significantly lower than GM-exposed IHCs within 10 min
(OHCsbase=0.97860.024, IHCsbase=1.04660.024, t(8)=1.99,
p,0.05).
GM NADH Effect: NADH Reduction Assay
Given that increased NADH oxidation did not appear to
mediate the GM NADH effect in the previous experiment, the
GM NADH effect may arise from a GM-induced decrease in
NADH reduction/production. If so, NADH Fl should decrease
when NADH production is dramatically decreased and NADH
oxidation (conversion to non-Fl NAD
+) is maintained.
NADH production was assessed in control and GM-treated
cochleae after NADH oxidation was inhibited with NaCN
(10 mM). NaCN increases NADH Fl in cochlear I/OHCs bathed
in T1 buffer (see controls, Fig. 4A, B). Similar to the dramatic and
distinct T2-mediated increase in NADH Fl observed in basal turn
OHCs, the largest NaCN-induced increase in NADH Fl was
observed in basal turn OHCs (Fig. 4B). Specifically, NADH
production capacity, measured as NADH Fl intensity when
NADH oxidation is inhibited, was greater in basal turn OHCs,
relative to apical turn OHCs (at 30 min: OHCsapex=1.0660.014,
OHCsbase=1.15660.032, t(7)=2.514, p,0.05).
If GM limited NADH production, NaCN-mediated increases
in NADH Fl would be similarly limited in GM pretreated I/
OHCs. Pretreatment with 300 mg/ml GM (30 min) limited
NADH production capacity in apical and basal turn I/OHCs
(Fig. 4A, B). Although NADH Fl in apical turn I/OHCs was
significantly decreased by GM, GM-pretreated apical I/OHCs
were similar to controls after 30 min. In contrast, NADH Fl in
Figure 3. T2 buffer increased NADH reduction/production but failed to prevent the GM NADH effect. A) Apical turn I/OHCs display
transient, significant increases in NADH Fl when bathed in T2 buffer (nT1=5,n T2=4). B) Basal turn OHCs display a significant and prolonged increase
in NADH Fl in T2 buffer while basal turn IHCs do not (nT1=5,n T2=4). C) T2-bathed, apical turn I/OHCs display moderate decreases in NADH Fl during
acute GM exposure (nGM=4,n Cont=5). D) T2-bathed basal turn OHCs, not basal turn IHCs, display significant and prolonged decreases in NADH Fl
during GM exposure (nGM=5,n Cont=5). T2 imaging buffer contained 10 mM glucose, 3 mM glutamate and 2 mM pyruvate. *=p,0.05, **=p,0.01.
doi:10.1371/journal.pone.0038471.g003
Gentamicin Inhibits Cochlear Hair Cell Metabolism
PLoS ONE | www.plosone.org 5 June 2012 | Volume 7 | Issue 6 | e38471basal turn I/OHCs was significantly limited throughout the
NaCN exposure period (p,0.001). Suppression of NADH Fl
after GM exposure was similar for apical turn low-frequency I/
OHCs (Fig. 4C). In contrast, suppression of NADH Fl was
greater in GM-exposed, basal turn high-frequency OHCs than in
basal turn IHCs (Fig. 4D, p,0.01) during the initial 20 min of
the NaCN exposure period.
GM Suppresses NADH Fl via Krebs Cycle Inhibition
Succinate dehydrogenase (SDH), the only dual-role enzyme in
mitochondrial metabolism, participates in both the Krebs cycle
(NADH reduction) and electron transport chain (NADH oxida-
tion). With subunits A and B facing the mitochondrial matrix and
subunits C and D bound to inner mitochondrial membrane, SDH
couples the oxidation of succinate to fumarate in the Krebs cycle
and the reduction of ubiquinone to ubiquinol in the electron
transport chain [37]. SDH histochemistry is a long standing, semi-
quantitative method for determining if cochlear I/OHC are
metabolically compromised [31]. As a second assessment of GM’s
capacity to decrease NADH production, Krebs cycle activity,
indicated by SDH activity, was measured in cochlear I/OHCs
after acute GM exposure (1 h, 300 mg/ml, T1 buffer). In apical
turn, low-frequency regions of the cochlea, IHCs maintained SDH
activity after GM treatment. In apical OHCs SDH activity was
significantly decreased by GM (OHCscontrol=178.5563.21,
OHCsGM=159.1165.947 arbitrary units, t(15)=2.659, p,0.01,
Fig. 5A). An OHC-specific decrease in SDH activity was also
observed in basal turn, high-frequency regions of the cochlea
(OHCscontrol=170.3967.652, OHCsGM=148.1567.56 A.U.,
t(15)=2.019, p,0.05, Fig. 5B).
Discussion
Examination of baseline NADH Fl intensities in high- and low-
frequency I/OHCs revealed endogenous differences in I/OHC
mitochondrial metabolism. Specifically, OHC NADH Fl was
greater than IHC NADH Fl in both apical and basal regions of the
cochlea (Fig. 1A,B). The largest difference in baseline NADH Fl
occurred between basal turn IHCs and OHCs. Since baseline
NADH Fl represents the balance between NADH reduction and
oxidation, absolute differences in NADH Fl during maximum
NADH oxidation and reduction were also measured. Absolute
changes in NADH Fl in basal turn OHCs were significantly larger
than the changes observed in basal turn IHCs. Relative changes in
Figure 4. Acute GM exposure decreases NADH reduction/production capacity. A) NaCN-induced increases in NADH Fl in apical turn I/OHCs
are significantly diminished when I/OHCs are pretreated with GM (300 mg/ml, nGM=8,n Cont=6). B) GM pretreatment (300 mg/ml) abolishes NaCN-
induced increases in NADH Fl in basal turn I/OHCs (nGM=7,n Cont=6). C) Mean changes in NADH Fl between control and GM-exposed I/OHCs were
similar in apical turn I/OHCs and D) greater in basal turn OHCs, relative to basal turn IHCs. Experiments conducted in T1 buffer. *=p,0.05,
**=p,0.01.
doi:10.1371/journal.pone.0038471.g004
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basal regions of the cochlea. For the purposes of the current
report, the I/OHC relative redox scale represents the maximum
range of NADH Fl capable of occurring in cochlear HCs. This
scale will be used to assess the relative oxidative and reductive
impact of elevated glucose and GM on I/OHC mitochondrial
metabolism.
The current report shows basal turn, high-frequency OHCs are
metabolically responsive to GM and elevated glucose concentra-
tions while high-frequency IHCs and low-frequency I/OHCs are
substantially less sensitive. Basal turn OHCs displayed a robust
increase in NADH Fl when exposed to high glucose, Krebs cycle
substrate modified media (Fig. 3A, B). Likewise, the GM NADH
effect was preferentially observed in basal turn OHCs (Fig. 2A, B).
This metabolic predisposition may bias basal turn OHC responses
to a variety of cochlear insults, particularly those directly involving
energy metabolism and ROS production.
GM was shown to rapidly and preferentially inhibit mitochon-
drial metabolism in basal turn, high-frequency OHCs (Fig. 2A, B).
The observed decrease in mitochondrial function is consistent with
the well-known enhanced susceptibility of high-frequency basal
turn OHCs to preferentially undergo apoptosis after AG exposure.
In light of the relative redox scale of maximum NADH oxidation
(,30% decrease in NADH Fl) in basal turn OHCs, the ,12%
decrease in NADH caused by GM suggests that up to a third of
the utilizable NADH pool was oxidized during GM exposure. This
basal turn, OHC-specific effect suggests high-frequency OHCs
may undergo as much as a 33% decrease in ATP production
during acute GM treatment while ATP production in apical turn
I/OHCs and basal turn IHCs is relatively undisturbed. This high-
frequency OHC-specific decrease in NADH, and presumably
ATP production capacity, is consistent with other studies
indicating diminished ATP availability triggers apoptosis while
large-scale losses of ATP trigger necrosis in a variety of cell types
[25,26,38]. Given that ototoxic HC death is frequently attributed
to apoptosis [39–42] rather than necrosis or caspase-independent
mechanisms [7,43], the decrease in NADH Fl described in the
current report is consistent with a moderate decline in ATP
production capacity subsequent commitment of cochlear HCs to
undergo apoptosis.
Although one other report has described a rapid decrease in
OHC metabolism during acute GM exposure [34], this is the first
report to describe a mechanism for the observed decrease in
NADH Fl. As previously mentioned, steady-state NADH Fl
represents the net activities of two opposing processes; Krebs
cycle-mediated NADH reduction and electron transport chain-
mediated NADH oxidation. T2 buffer-produced a 10–15%
increase in NADH Fl in basal turn OHCs which approached
the maximum NADH reduction capacity for basal turn OHCs (,
20%). Surprisingly, the GM NADH effect remained undeterred.
Furthermore, apical turn I/OHCs, which failed to display
significant GM-induced changes in NADH Fl in T1 buffer
(baseline), displayed transient, yet significant, decreases in NADH
Fl when exposed to GM in T2 buffer (Fig. 3A). The observed T2-
mediated increase in NADH production in apical turn I/OHCs
indicates apical low-frequency HCs assumed activated metabolic
profiles similar to those observed in high-frequency OHCs. As
a result, the GM NADH effect was only observed in apical turn I/
OHCs bathed in T2 buffer.
These findings also suggest that, if apical turn I/OHCs assume
activated high-frequency OHC-like metabolic profiles, GM-
triggered ROS production in apical turn I/OHCs would be
enhanced. Specifically, the coupling of oxidative phosphorylation
and ATP synthesis is not absolute. During normal respiration, 2–
3% of the oxygen utilized by a given cell will form ROS after
electrons prematurely exit the electron transport chain [44]. When
the NADH/NAD
+ ratio and/or the reduced/oxidized ubiquinone
pool are altered, the fidelity of ‘appropriate’ electron transfer
decreases resulting in ROS production [45–47].
The GM-NADH effect was essentially doubled in high-
frequency basal turn OHCs bathed in T2 buffer (Fig. 3D), relative
to T1 buffer (Fig. 2B). If maximum NADH oxidation causes
a ,30% decrease in NADH Fl in basal turn OHCs, the observed
,20% GM-induced decrease in NADH in high-frequency OHCs
bathed in T2 buffer suggests nearly two thirds of the utilizable
NADH pool may be oxidized during GM exposure. This also
suggests a large decrease in ADP phosphorylation potential and
consequently ATP production capacity in OHCs. As indicated
above, ROS production is predicted to also increase in T2-bathed,
relative to T1-bathed high-frequency I/OHCs. The appearance of
Figure 5. Acute GM exposure decreased succinate dehydrogenase activity OHCs. A) Apical turn OHCs display significant decreases in SDH
activity during acute GM exposure, while apical turn IHCs do not (nGM=9,n Cont=8). B) Basal turn OHCs, not IHCs, display significant decreases in SDH
activity during GM exposure (nGM=9,n Cont=8). *=p,0.05, **=p,0.01.
doi:10.1371/journal.pone.0038471.g005
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GM NADH effect observed in basal turn OHCs suggests
increasing NADH production acutely promotes compensatory
increases in NADH oxidation. Akin to the difference in distances
required to stop a slow-moving or rapidly-moving car, GM-
induced decreases in NADH production capacity would produce
a larger, yet transient decrease in NADH in I/OHCs with elevated
baseline NADH reduction and oxidation.
To determine if the GM NADH effect is caused by diminished
NADH reduction, NADH production capacity was evaluated.
Given that NaCN inhibits NADH oxidation, NADH production
capacity, or the amount of NADH capable of being produced at
any given time can be assessed. NADH production capacity was
diminished in I/OHCs pretreated with GM (Fig. 4). Although
NADH production capacity was significantly decreased in apical
and basal turn I/OHCs, a profound and prolonged decrease in
NADH production capacity was observed in high-frequency
OHCs. Notably, NADH production capacity in GM-treated
apical turn I/OHCs reached control levels after 30 min. I/OHCs
also maintained similar NADH levels throughout the experiment.
In stark contrast, high-frequency, basal turn OHCs displayed
a robust decrease in NADH production capacity after GM
treatment. Unlike low-frequency I/OHCs, high-frequency I/
OHCs did not recover from GM-induced decreases in NADH
production capacity. In concert, the above experiments clearly
indicate a GM-induced decrease in NADH production capacity
occurs within minutes of GM application. Furthermore high-
frequency OHCs, known to be preferentially damaged by GM,
display the greatest decline in NADH and NADH production
capacity. To this end, the GM NADH effect is not likely to be due
to an increase in NADH oxidation. However, this is difficult to
confirm when NADH reduction is compromised. Further studies
will need to be performed to confirm this observation.
As an additional verification of the observed GM-induced
decrease in NADH production capacity, SDH activity was
measured in GM-treated cochlear I/OHCs. In light of the fact
that SDH participates in both the Krebs cycle and electron
transport chain, assays of SDH activity assays must be cautiously
interpreted. Although the activity of other enzymes in the Krebs
cycle can be measured (citrate synthase, aconitase, to name just
two), SDH is the only Krebs cycle enzyme that can be assayed in
intact tissues. Likewise, accurate measurements of cell-specific
oxygen consumption, an additional method for measuring
metabolic activity, are difficult in heterogeneous cell populations.
Recall that the current study investigates metabolic differences
between cochlear I/OHCs. Given that 1) cochlear I/OHCs reside
within the cochlear partition which contains both sensory and
supporting cells, 2) OHCs are nearly three times more numerous
than IHCs (see Fig. 1C,D) and 3) there is no way to isolate large
quantities of unperturbed IHCs and OHCs for IHC- and OHC-
specific mitochondrial analyses, SDH activity is the best assay for
IHC- and OHC-specific Krebs cycle analyses. Likewise, a recent,
extensive review of the actions of SDH indicates SDH/Complex II
of the mitochondrial respiratory system is ‘the central mediator’ of
most pathologies involving oxidative damage [45]. Akin to the
observed GM-induced alterations in NADH, SDH activity is also
shown to modulate NADH/NAD
+ ratios in multiple cell types.
In the current report, acute GM exposures decreased SDH
activity in OHCs (Fig. 4). Although others have shown that longer
GM exposures ($4 h) decrease SDH activity in I/OHCs [48], this
is the first report to show GM rapidly (1 h) decreases SDH activity.
When the observed decrease in SDH activity is considered in
conjunction with GM-induced decreases in NADH Fl intensity,
a GM-induced deficit in NADH reduction is indicated. One
function of SDH is to donate electrons, from succinate, to the
ubiquinone pool in the electron transport chain. NADH also
donates electrons to of the electron transport chain (complex I).
Therefore, NADH could continue to donate electrons to the
electron transport chain in the absence of succinate oxidation.
Recall, however, that NADH is the primary reducing equivalent
generated in the Krebs cycle. If SDH is no longer capable of
oxidizing succinate to fumarate, NADH production and Krebs
cycle activity would be significantly impeded. Given that the
amount of NADH generated during b-oxidation and glycolysis or
regenerated via the malate-aspartate shuttle is significantly less
than Krebs cycle-produced NADH [49], a net decrease in NADH
would occur when SDH activity is decreased. As such NADH
oxidation (complex I, electron transport chain) could continue
while NADH reduction (Krebs cycle) is reduced. Once the NADH
pool is exhausted, as indicted by the net decrease in NADH Fl,
electron transport dysfunction and decreased ATP production
would ensue.
A number of groups have shown a decrease in HC viability,
cytochrome c release, AIF release, and mitochondrial permeability
transition pore (MPTP) opening using similar AG exposures
(recent reviews [50–53]). Of particular importance, Dehne et al.
[16] observed opening of the MPTP in cochlear outer (not inner)
HCs required $4 h of exposure to GM at considerably higher
concentrations (500–1000 mM) than what was used in the current
report (300 mg/ml , 150 mM). Furthermore, cyclosporin A,
a MPTP inhibitor, did not significantly increase OHC survival
within this time frame, although an increase was observed. Given
that rapid opening of the MPTP would cause a decrease in NADH
Fl, the 300 mg/ml GM dose used in the current study was
purposely chosen to 1) be closer to a physiologically relevant range
and 2) avoid rapid opening of the MPTP. MPTP opening, an
event that is certainly not requisite for excess ROS production, is
the end result of gross perturbations in mitochondrial metabolism.
As such, we do not predict opening of the MPTP in the acute GM
exposures utilized in the current report. Rather the current studies
describe how AGs directly and differentially alter IHC and OHC
mitochondrial metabolism in the absence of MPTP opening. To
this end, it is fully anticipated that sustained GM-induced
alterations NADH metabolism (.4 h) would reduce hair cell
viability, increase the probability of MPTP opening and trigger the
release of mitochondrial-specific pro-apoptotic signaling factors as
observed in other cell populations [54]. Indeed, our findings are
also consistent with the work of Alharazneh et al. [13], who
showed that exposure to 0.25 mM GM for 1 h followed by a 48 h
recovery period resulted in a tonotopic loss of OHCs in the basal
and middle turns while HC loss was negligible immediately
following GM exposure. When considered in conjunction with the
results described in the current study, 1 h of exposure to GM
(250–300 mg/ml) preferentially produces metabolic dysfunction in
high-frequency, basal turn OHCs that appear to be sufficient to
trigger a pro-apoptotic cascade of events which ultimately lead to
the demise of high-frequency OHCs.
Given that the density of functional mitochondria (Fig. 1E) is
greater in OHCs than IHCs regardless of cochlear location,
elevated baseline NADH Fl may be due to differences mitochon-
drial densities. This explanation does not, however, seem sufficient
to explain why 1) T2 buffer preferentially enhanced NADH Fl in
high-frequency, not low-frequency OHCs, 2) why low-frequency
I/OHCs exhibit similar responses to GM and, 3) why the GM-
NADH effect was greatest in high-frequency, basal turn OHCs.
These results indicate the endogenous metabolic profiles of I/
OHCs are fundamentally different. As such, high-frequency basal
turn OHCs appear to be metabolically biased to rapidly respond
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glucose and GM exposure. This report identifies endogenous
differences in I/OHC NADH metabolism and a GM-mediated
decrease in NADH production capacity and Krebs cycle activity
within minutes of GM application. Multiple ROS production
mechanisms have been proposed in studies using prolonged AG
exposures ($24 h) [55–57]. Given that AGs have been shown to
alter mitochondrial protein synthesis [14,15], any study of AG
ototoxicity must differentiate between immediate and long-term
alterations in mitochondrial function. Of particular significance,
the results described herein occur on a timescale too short to
include GM-induced changes in mitochondrial protein synthesis
and turnover. Instead these results strongly suggest GM directly
alters mitochondrial function in cochlear I/OHCs.
Although SDH and NADH are involved, the exact nature of
this interaction awaits further study. As such, the novel and
intriguing findings of the current report will undoubtedly function
as a catalyst for future studies aimed at deciphering the true
mechanism(s) by which GM disrupts mitochondrial metabolism
and presumably triggers mitochondrial ROS production. Notably,
the NOX family of NADPH oxidases is another recognized source
of ROS in cochlear HCs [58–60]. NOX-mediated redox signaling
is, however, unlikely to trigger ROS production during the early
stages of GM exposure described in the current report. Specifi-
cally, several groups have shown NOX-dependent ROS pro-
duction in HCs requires NOX activation, a process requiring over
6 h to trigger significant increases in ROS [58,60,61]. Therefore,
the endogenous metabolic biases observed in the current report
indicate AG-mediated ROS production in cochlear HCs is likely
the result of direct mitochondrial alterations and rapid metabolic
dysfunction.
Given that AG-induced ROS production is a well-documented
trigger for AG ototoxicity and irreversible HC loss (recent reviews
[50,55]) and decreased NADH levels are associated with profound
mitochondrial ROS production (recent review [45]), the current
study highlights a need to further elucidate the role(s) mitochon-
dria in mediating AG ototoxicity and, potentially, numerous other
HL pathologies including ARHL and NIHL.
Materials and Methods
Cochlear Explants
All experiments were performed using acutely-cultured, intact
cochlear (organ of Corti) explants. Cochleae obtained from CO2
asphyxiated postnatal day 6 (P661d) FVB mice were dissected in
HEPES-buffered L-15. Intact explants were acutely cultured (24–
30 h) at 37uC and 5% CO2 in Dulbecco’s modified Eagle’s
Medium/F12 medium (Invitrogen, Carlsbad, CA., USA) supple-
mented with 10% FBS (Invitrogen). The number of cochlear
explants examined in each experiment and condition is indicated
in the respective figure caption. Cochlear preparations with intact,
viable HCs were maintained at 3264uC in one of two modified
Tyrodes buffers (see below) throughout imaging. During each
experiment I/OHCs located in apical, low-frequency (20% of
cochlear length) and/or basal, high-frequency (80% of cochlear
length) regions were compared. Unless otherwise noted, reagents
and solutions were obtained from Sigma-Aldrich (St. Louis, MO.,
USA). Animal care and use procedures were approved by the
Creighton University Animal Care and Use Committee.
Imaging Methods
Baseline modified Tyrodes imaging buffer (T1) contained 5 mM
glucose, 135 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1.8 mM
CaCl2 and 20 mM HEPES. Enhanced modified Tyrodes imaging
buffer (T2) was generated by adding Krebs cycle substrates (3 mM
glutamate, 2 mM pyruvate) and increasing the glucose content of
T1 to 10 mM. Each solution was adjusted to 31065 mOsm and
a pH of 7.3560.05.
Endogenous NADH was excited using femtosecond pulses of
740 nm light from a MaiTai DeepSee laser (Newport, Irvine, CA,
USA) using an upright Zeiss LSM 510 META NLO scanning
confocal microscope and a 606, 0.9 N.A. water immersion lens
(Olympus, Center Valley, PA, USA). Successive focal planes
(2.5 mm apart) were imaged through each cochlear preparation. Z-
stack image series were obtained at 10 min intervals. Non-
descanned NADH Fl was collected using a 500 nm long pass
dichroic mirror (500 DCXR, Chroma, Bellows Falls, VT, USA)
and 460/80 bandpass (BP) filter. During NADH imaging, one
baseline image was obtained before application of 300 mg/ml GM.
Assays of Metabolic Activity
Endogenous, steady-state NADH Fl intensities were obtained by
imaging apical and basal turn I/OHCs under identical imaging
parameters using T1 buffer. To determine if absolute and/or
relative differences in I/OHC NADH oxidation and reduction
occur, 10 mM Carbonyl cyanide-p-trifluoromethoxyphenylhydra-
zone (FCCP) or 10 mM sodium cyanide (NaCN) were adminis-
tered, respectively. Others have shown these concentrations are
sufficient to cause maximum NADH reduction and oxidation in
cochlear HCs [35]. NADH Fl changes, calculated as the difference
in NADH Fl before and 10 min after each treatment, were
compared in apical, low-frequency and basal, high-frequency
regions of the cochlea. NaCN was also used to calculate NADH
production capacity before and after 300 mg/ml GM. By
specifically inhibiting cytochrome C oxidase (mitochondrial
complex IV), NaCN prevents NADH oxidation while Krebs
cycle-mediated NADH production remains active. The net result
is an increase in the NADH/NAD
+ ratio indicated by an increase
in NADH Fl. Given that NADH oxidation (conversion to non-Fl
NAD
+) is inhibited, NaCN-induced changes in NADH Fl are
indicative of the total amount of NADH produced, or the NADH
production capacity for each cell. NaCN was applied 30 min after
300 mg/ml GM.
Given that cochlear I/OHCs are 1) surrounded by supporting
cells in the cochlear partition and 2) are extremely difficult to
individually isolate in sufficient quantities to perform cell type
specific analyses of metabolic activity, options for measuring
metabolic activity are limited to those applicable to intact cells.
Succinate dehydrogenase (SDH) histochemistry is a long standing
technique used to measure metabolic activity and HC viability
[28–30,62–66]. SDH histochemistry performed similarly to pre-
vious reports [29,67], was used to semi-quantitatively measure
SDH/Krebs cycle activity in control and GM exposed (1 h)
cochlear preparations in conjunction with NADH Fl changes.
Cochlear preparations were exposed to a SDH staining solution
containing 1:1:2 parts of 0.2 M sodium succinate, 0.2 M
phosphate buffered saline (pH 7.6), 0.1% tetranitro-blue tetrazo-
lium, respectively. After 45 min of exposure to the SDH staining
solution at 37uC, cochlear cultures were fixed in 10% formalin for
2 h. Transmitted light images of the insoluble tetranitro-blue
precipitate, indicative of SDH activity, were obtained using the
transmitted light detector of the Zeiss confocal microscope
previously described.
Functional mitochondria were labeled with Mitotracker Red
CM-H2XRos (Invitrogen). Briefly, cochlear explants were in-
cubated in 200 nM Mitotracker Red in T1 buffer for 10 min at
37uC and 5% CO2. Next, cochlear explants were rinsed and
immediately imaged under identical conditions in T1 buffer.
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and collected using a 565–615 nm emission filter. Relative
differences in Mitotracker Red Fl were calculated and compared.
Image Analysis
As previously mentioned, successive focal planes (2.5 mm apart)
were collected throughout each preparation. To compensate for
differences in I/OHC volume, average NADH and Mitotracker
Red Fl in each I/OHC was calculated by measuring the respective
Fl in each consecutive focal plane. Individual values were averaged
to determine HC-specific Fl intensities. These intensities were
pooled to determine the mean I/OHC values for each cochlear
preparation. Individual transmitted light images of nitro-blue
tetrazolium accumulation were analyzed to determine SDH
activity in I/OHCs. Raw pixel data was analyzed using Image J
[68] and evaluated using Students t-test analyses performed in
Excel. Data were plotted using OriginLab (Northampton, MA,
USA).
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